Kevin Kunzmann

A smartwatch and patch product from Biobeat will allow physicians and patients to monitor blood pressure, oxygenation, and heart rates in both inpatient and outpatient settings.

What is the large-scale study looking to bring to clinical respiratory health understanding?

In what ways do the respiratory conditions differentiate in progression and care options?

A 600-city analysis of particulate matter found daily exposure is linked to worsened mortality rates, particularly in areas with higher mean temperatures.

How does the highly recommended practice benefit patients, and where are its gaps in care?

The OneDraw A1C Test System was granted marketing clearance based on the strength of clinical findings reported at ADA 2019.

How do physicians help manage their patient's sleep health for best outcomes?

A pattern of poor sleep could lead to worsened psychiatric wellbeing—and eventually, memory loss.

Stacy Brethauer, MD, will lead discussion on the influence of BMI on bariatric surgery, and the influence of obesity on public health.

Clinicians have indicated which symptom subtypes are associated with a greater risk of cardiovascular conditions in patients with OSA.

Children and adolescents have considerably fewer control therapy options for T2D. The GLP-1 agonist could be the first of its class for pediatric indication.

What criteria should physicians follow to properly diagnose insomnia and its many comorbid conditions in older patients?

The TAVR treatment was associated with a 46% reduction in one-year event risk among patients at low risk of open heart surgery.

The once-daily capsule therapy is the first drug indicated for the rare disease since ruxolitinib in 2011.

The current vaccine strategy is effective, but lacks a streamlined approach.

Kala Pharmaceuticals will continue with an ongoing phase 3 trial assessing the solution, and could resubmit its NDA in 2020.

The investigative monoclonal antibody from Regeneron shows significant benefit for patients with the rare, severe homozygous familial hypercholesterolemia.

A look into the reasoning behind the vaccine recommendations set by the CDC's Advisory Committee on Immunization Practice.

The first longitudinal study to assess air pollution and emphysema progression provides novel long-term findings.

Robert G. Gish, MD, and the Global Liver Institute join up for a talk on all things hepatology.

Multiple conditions, especially those common in the elderly, can greatly increase the risk of insomnia.

A clinical breakdown of what constitutes primary, secondary, chronic, and acute forms of insomnia.

How do the states with the longest-running legislation permitting MAID compare?

The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

The epicutaneous immunotherapy patch BLA was previously submitted to the FDA last year, but withdrawn due to concerns over manufacturing procedure and quality control.

The FDA has been informed by the therapy's manufacturer that data was manipulated during its animal testing phase.

New phase 3 data will evidence an FDA application for the biologic as an add-on therapy for patients aged 6-11 years with AD.

A new study found significantly greater COPD development risk among middle-aged women who eat processed meat—and doubly worse risk for those who also smoke and have unhealthy diets.